Molecular profiling of clear cell ovarian carcinoma.

被引：0
|
作者：
Friedlander, Michael
Russell, Kenneth
Millis, Sherri Z.
Gatalica, Zoran
Voss, Andreas
机构：
[1] Prince Wales Hosp, Sydney, NSW, Australia
[2] Caris Life Sci, Basel, Switzerland
[3] Caris Life Sci, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.5516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5516
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Recurrence factors of stage I ovarian clear cell carcinoma.
    Takei, Yuji
    Fujiwara, Hiroyuki
    Machida, Shizuo
    Taneichi, Akiyo
    Takahashi, Suzuyo
    Takahashi, Yoshifumi
    Saga, Yasushi
    Suzuki, Mitsuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] The unique tumor immune microenvironment of clear cell ovarian carcinoma.
    Cun, Han T.
    Zhu, Ying
    Ferri-Borgogno, Sammy
    Sheng, Jianting
    Cheng, Rita
    Kim, Jae-Hoon
    Han, Gwan Hee
    Wong, Stephen T.
    Lu, Karen H.
    Mok, Samuel C.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Expression profiling in ovarian clear cell carcinoma identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
    Tsuchiya, A
    Sakamoto, M
    Yasuda, J
    Chuma, M
    Ohta, T
    Ohki, M
    Yasugi, T
    Taketani, Y
    Hirohashi, S
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (06): : 2503 - 2512
  • [4] Comprehensive genomic profiling in Chinese patients with clear cell renal cell carcinoma.
    Jin, Baiye
    Wang, Yimin
    Luo, Jindan
    Wang, Yu
    Ren, Shuang
    Wu, Chin-Lee
    Zhang, Peng
    Mei, Lei
    Wang, Kai
    Wang, Shuang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Gene expression profiling predicts survival in clear cell renal cell carcinoma.
    Tan, MH
    Teh, BT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 386S - 386S
  • [6] Molecular pathogenesis of ovarian clear cell carcinoma
    Gounaris, Ioannis
    Brenton, James D.
    FUTURE ONCOLOGY, 2015, 11 (09) : 1389 - 1405
  • [7] Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma.
    Ji, Jing
    Li, Zhigui
    Sherman, Emily
    Osagie, Oloruntoba
    Mi, Shijun
    Soble, Whitney
    Li, Jessie
    Huang, Gloria
    REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 107A - 107A
  • [8] Evaluation of ATR Inhibitors for Targeted Therapy of Ovarian Clear Cell Carcinoma.
    Ji, Jing
    Li, Zhigui
    Sherman, Emily
    Osagie, Oloruntoba
    Mi, Shijun
    Huang, Gloria
    REPRODUCTIVE SCIENCES, 2020, 27 (SUPPL 1) : 118A - 118A
  • [9] Arginine deprivation as a potential targeted therapy for clear cell ovarian carcinoma.
    Xiao, Jennifer
    Ji, Ye
    Cochrane, Dawn R.
    Tessier-Cloutier, Basile
    Hoang, Lien N.
    Wang, Yikan
    Cheung, Angela
    Chow, Christine
    Colborne, Shane
    Hughes, Christopher
    Morin, Gregg B.
    Huntsman, David G.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 29 - 29
  • [10] IDENTIFICATION OF POTENTIAL REGULATORY VARIANTS FOR THE DEVELOPMENT OF OVARIAN CLEAR CELL CARCINOMA.
    Kim, J.
    Jeong, S. Y.
    Kim, M. S.
    Paik, E. S.
    Kim, T. J.
    Lee, J. W.
    Kim, B. G.
    Bae, D. S.
    Choi, C. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 170 - 170
12345